Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors

BACKGROUND: It is not known which type 2 diabetes mellitus (T2DM) patients would most benefit from dipeptidyl peptidase-4 (DPP-4) inhibitor treatment. We aimed to investigate the predictors of response to DPP-4 inhibitors considering degree of DPP-4 inhibition. METHODS: This study is a post hoc anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Sangmo, Jung, Chang Hee, Han, Song, Park, Cheol-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831807/
https://www.ncbi.nlm.nih.gov/pubmed/33866774
http://dx.doi.org/10.4093/dmj.2020.0253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831807/
https://www.ncbi.nlm.nih.gov/pubmed/33866774
http://dx.doi.org/10.4093/dmj.2020.0253

Ejemplares similares